Sector Focus


Caliber has successfully planned with both venture backed private development stage companies and publicly traded biopharmaceutical companies. We understand the unique challenges of emerging companies as well as global biotech organizations and we have developed a keen sense of what it takes to discover and develop biologically derived treatments to enhance the quality of care in markets with substantially under met medical needs.


Isis Pharmaceuticals, Inc.

Isis Pharmaceuticals, Inc. is a drug discovery and development company focused exclusively on the untapped therapeutic target, RNA. Isis has successfully commercialized the world's first antisense drug, Vitravene.

Search Projects

  • Vice President, Drug Development
  • Executive Director, Drug Development